Cholangiocarcinoma (Bile Duct Cancer) Clinical Trials

Find Cholangiocarcinoma (Bile Duct Cancer) Clinical Trials Near You

Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma: a Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

A multicentre, parallel group, open label, randomized controlled trial comparing endobiliary RFA prior to metal stent placement with stent placement only in patients with inoperable perihilar cholangiocarcinoma.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• 18 years or older.

• Capable of providing written and oral informed consent.

• Histological or cytological proof of perihilar CCA (adenocarcinoma).

• Perihilar biliary obstruction with an indication for drainage with uSEMS.\*

• Advanced (no candidate for surgical resection) due to metastases, vascular or lymph node (N2) involvement on imaging or during staging laparoscopy according to multidisciplinary team (MDT).

⁃ Only patients with pCCA are eligible however in case of reasonable doubt between intrahepatic CCA with a perihilar biliary obstruction or massforming pCCA, patients can be included.

Locations
Other Locations
Netherlands
Amsterdam UMC location VUmc
RECRUITING
Amsterdam
Contact Information
Primary
Esmée Smit
e.smit1@amsterdamumc.nl
+31204440613
Time Frame
Start Date: 2022-10-22
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 122
Treatments
Experimental: Endobiliary RFA + stent placement
Active_comparator: Stent placement only
Related Therapeutic Areas
Sponsors
Collaborators: UMC Utrecht, University Medical Center Groningen, Medisch Spectrum Twente, University Hospital Prague (IKEM), Prague, Czech Republic, St. Antonius Hospital, Universitaire Ziekenhuizen KU Leuven, Clinical Hospital Colentina, Maastricht University Medical Center, Orlando Health, Inc., University Hospital, Ghent, Erasmus Medical Center, Leiden University Medical Center
Leads: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials